Patient characteristics
| Variables . | Number of patients . |
|---|---|
| Median age, y | 61 (range, 41-68) |
| Male:female | 2:1 |
| ECOG performance status >1 | 7 |
| High lactic dehydrogenase serum level | 6 |
| High CSF protein concentration* | 6 |
| Involvement of deep areas | 5 |
| IELSG risk score | |
| Low | 1 |
| Intermediate | 9 |
| High | 2 |
| Intraocular disease | 1 |
| Meningeal dissemination | 0 |
| Previous lines | |
| Previous lines ≥2 | 7 |
| Previous ASCT | 3 |
| Previous WBRT | 3 |
| Both ASCT + WBRT | 4 |
| Refractory to previous lines | 7 |
| Variables . | Number of patients . |
|---|---|
| Median age, y | 61 (range, 41-68) |
| Male:female | 2:1 |
| ECOG performance status >1 | 7 |
| High lactic dehydrogenase serum level | 6 |
| High CSF protein concentration* | 6 |
| Involvement of deep areas | 5 |
| IELSG risk score | |
| Low | 1 |
| Intermediate | 9 |
| High | 2 |
| Intraocular disease | 1 |
| Meningeal dissemination | 0 |
| Previous lines | |
| Previous lines ≥2 | 7 |
| Previous ASCT | 3 |
| Previous WBRT | 3 |
| Both ASCT + WBRT | 4 |
| Refractory to previous lines | 7 |
ECOG, Eastern Cooperative Oncology Group; IELSG, International Extranodal Lymphoma Study Group.
Lumbar puncture was contraindicated in 3 patients; CSF protein concentration was considered as unfavorable feature in IELSG risk score in these patients.